| 英語名 | 研究コード | 研究開発ステージ | 会社 | オリジナル製品名 | 最初に承認をした国 | 最初の適応症 | 最初に承認を受けた会社 | 承認された日付 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|---|---|---|---|---|
| Etoposide phosphate | BMY-40481 | Approved | Bristol-Myers Squibb Company | Etopophos | United States | Lymphoma, Non-Hodgkin; Multiple Myeloma; Testicular Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Hodgkin Disease; Small Cell Lung Carcinoma | Cheplapharm Arzneimittel Gmbh | 1996-05-17 | Lung Neoplasms; Neoplasms, Plasma Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Ewing; Brain Neoplasms; Lymphoma, Follicular; Testicular Neoplasms; Lymphoma; Germinoma; Neoplasms, Gonadal Tissue; Breast Neoplasms; Lymphoma, Non-Hodgkin; Thrombocytopenia; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; Myelodysplastic-Myeloproliferative Diseases; Neoplasms, Germ Cell and Embryonal; Uterine Cervical Neoplasms; Neoplasm Metastasis; Neoplasms; Solid tumours; Ovarian Neoplasms; Kidney Neoplasms; Neutropenia; Plasmacytoma; Myelodysplastic Syndromes; Small Cell Lung Carcinoma; Hodgkin Disease; Leukemia; Myeloproliferative Disorders; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Multiple Myeloma; Central Nervous System Neoplasms; Adrenocortical Carcinoma; Neuroblastoma; Sarcoma | 詳細 |